Prevalence and impact of posttraumatic stress disorder-like symptoms on patients with fibromyalgia syndrome.
Prevalence and impact of posttraumatic stress disorder-like symptoms on patients with fibromyalgia syndrome.
复制标题
纤维肌痛综合征患者创伤后应激障碍样症状的患病率和影响。
DOI：
10.1097/00002508-200006000-00006
复制
发表时间：
2000
期刊：
影响因子：
--
通讯作者：
Okifuji,A
中科院分区：
文献类型：
--
作者：
Sherman,JJ;Turk,DC;Okifuji,A
目的：创伤性事件可导致一系列症状，包括噩梦，反复和侵入性回忆，避免与创伤性事件相关的想法或活动，以及觉醒增加的症状，如失眠和过度警觉。这些创伤后应激障碍（PTSD）样症状经常在慢性疼痛综合征患者中观察到。人们对这两种现象如何相互作用知之甚少。本研究评估了纤维肌痛综合征（FMS）患者的PTSD样症状，并研究了PTSD样症状和与FMS.Design相关的问题之间的关系：连续93例患者进行了全面的FMS评估，并完成了自我报告问卷测量PTSD样症状，残疾和心理社会反应，他们的疼痛状况。受试者被分为两组的基础上自我报告的PTSD样symptoms.Results水平：约56%的样本报告临床显着水平的PTSD样症状（PTSD+）。PTSD+患者报告的疼痛（p< 0.01）、情绪困扰（p<0.01）、生活干扰（p< 0.01）和残疾（p< 0.01）水平显著高于没有临床显著水平的PTSD样症状（PTSD−）患者。超过85%的PTSD+患者和50%的PTSD−患者表现出严重的残疾。根据多维疼痛量表的反应，PTSD+患者的比例显着较小的被归类为自适应copers（15%）相比，PTSD−组（48.2%）。结论：结果表明，PTSD样症状在FMS患者中普遍存在，并可能影响适应这种慢性疾病。临床医生应该评估这些症状的存在，因为在治疗中未能注意到它们可能会阻碍成功的结果。
Objective:Traumatic events can result in a set of symptoms including nightmares, recurrent and intrusive recollections, avoidance of thoughts or activities associated with the traumatic event, and symptoms of increased arousal such as insomnia and hypervigilance. These posttraumatic stress disorder (PTSD)-like symptoms are frequently observed in persons with chronic pain syndromes. Little is known about how these two phenomena interact with one another. The present study evaluated PTSD-like symptoms in patients with fibromyalgia syndrome (FMS) and examined the relation between PTSD-like symptoms and problems associated with FMS.Design:Ninety-three consecutive patients underwent a comprehensive FMS evaluation and completed self-report questionnaires measuring PTSD-like symptoms, disability, and psychosocial responses to their pain condition. Subjects were divided in two groups based on level of self-reported PTSD-like symptoms.Results:Approximately 56% of the sample reported clinically significant levels of PTSD-like symptoms (PTSD+). The PTSD+ patients reported significantly greater levels of pain (p< 0.01), emotional distress (p< 0.01), life interference (p< 0.01), and disability (p< 0.01) than did the patients without clinically significant levels of PTSD-like symptoms (PTSD−). Over 85% of the PTSD+ patients compared with 50% of the PTSD− patients demonstrated significant disability. Based on response to the Multidimensional Pain Inventory, a significantly smaller percentage of PTSD+ patients were classified as adaptive copers (15%) compared with the PTSD− group (48.2%).Conclusions:Results suggest that PTSD-like symptoms are prevalent in FMS patients and may influence adaptation to this chronic illness. Clinicians should assess the presence of these symptoms, as the failure to attend to them in treatment may impede successful outcomes.